Clemson, Nephron driving pharmaceutical manufacturing with new benchtop industrial robot
Drug shortages have plagued the health care system for decades. Even prior to COVID-19, hospitals incurred more than $400 million in labor costs and alternative treatment options due to national generic drug shortages, especially for those administered via injection. More important, research shows shortages lead to adverse…









